{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:10:13Z","timestamp":1788775813384,"version":"build-2803163510"},"reference-count":31,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Organized cervical cancer screening aims to reduce the burden of advanced disease through earlier detection. However, a substantial proportion of women continue to present with locally advanced cervical cancer (LACC) requiring definitive chemoradiation. This study evaluated temporal changes in the demographic and clinicopathological characteristics of women with LACC treated with definitive chemoradiation before and after implementation of the organized cervical cancer screening program in Serbia. Methods: This retrospective single-center cohort study included 200 consecutive women with histologically confirmed LACC treated with definitive chemoradiation at the Institute of Oncology and Radiology of Serbia. Two cohorts were analyzed: a pre-screening cohort (2010\u20132011, n = 100) and a post-screening cohort (2022\u20132023, n = 100). Demographic and clinicopathological characteristics, including age, histopathology, FIGO stage, lymph node involvement, and geographic distribution, were compared. For study purposes, all patients were retrospectively restaged according to the FIGO 2018 classification using the best available clinical, radiological, and pathological data. Results: Women in the post-screening cohort were significantly older at diagnosis than those in the pre-screening cohort (mean age 54.9 vs. 49.7 years, p = 0.0046), with a substantially higher proportion of patients older than 64 years (28% vs. 2%, p &lt; 0.0001). Although the overall distribution of FIGO stages II\u2013IV did not differ significantly, a marked redistribution of FIGO 2018 substages was observed (p &lt; 0.0001), characterized by an increased proportion of stage IIIC disease and significantly more frequent lymph node involvement (63% vs. 41%, p = 0.0018). Geographic distribution remained stable, with most patients referred from the Belgrade administrative district. Conclusions: This study demonstrated clinically relevant temporal changes in the demographic and clinicopathological characteristics of women requiring definitive chemoradiation for LACC in Serbia. More than a decade after implementation of organized cervical cancer screening, tertiary referral centers continue to manage a substantial burden of patients with locally advanced disease requiring complex, resource-intensive treatment. These findings should not be interpreted as a direct evaluation of the national screening program but may provide valuable insights for healthcare planning in Serbia and other countries with similarly resource-constrained healthcare systems. Strengthening participation in organized screening, ensuring timely diagnostic evaluation, and improving HPV vaccination uptake remain essential to reduce the burden of advanced cervical cancer.<\/jats:p>","DOI":"10.3390\/cancers18172891","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:23:37Z","timestamp":1788773017000},"page":"2891","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evolving Clinicopathological Characteristics of Women with Locally Advanced Cervical Cancer Treated with Definitive Chemoradiation Before and After Implementation of Organized Cervical Cancer Screening in Serbia"],"prefix":"10.3390","volume":"18","author":[{"given":"Jelena","family":"Stani\u0107","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-0008","authenticated-orcid":false,"given":"Marija","family":"Popovi\u0107-Vukovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2063-4057","authenticated-orcid":false,"given":"Predrag","family":"Niki\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Clinic of Urology, University Clinical Center of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"}]},{"given":"Ivana","family":"\u0160ovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Radiological Diagnostics, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Luka","family":"Jovanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-1122","authenticated-orcid":false,"given":"Predrag","family":"Petra\u0161inovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5603-3942","authenticated-orcid":false,"given":"Marko","family":"Jovanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7531-7948","authenticated-orcid":false,"given":"Tatjana","family":"Arsenijevi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2715-3504","authenticated-orcid":false,"given":"Aleksandar","family":"Toma\u0161evi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"},{"name":"Department of Radiation Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"World Health Organization (2024). WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, WHO Press."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2018.10.026","article-title":"Validation of the 2018 FIGO cervical cancer staging system","volume":"152","author":"Matsuo","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer\u2014Update 2023*","volume":"33","author":"Cibula","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.6004\/jnccn.2025.0057","article-title":"Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines in Oncology","volume":"23","author":"Campos","year":"2025","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): A multicentre prospective cohort study","volume":"22","author":"Tanderup","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.brachy.2011.07.002","article-title":"American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy","volume":"11","author":"Viswanathan","year":"2012","journal-title":"Brachytherapy"},{"key":"ref_9","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"Tanderup","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Massobrio, R., Bianco, L., Campigotto, B., Attianese, D., Maisto, E., Pascotto, M., Redda, M.G.R., and Ferrero, A. (2024). New Frontiers in Locally Advanced Cervical Cancer Treatment. J. Clin. Med., 13.","DOI":"10.3390\/jcm13154458"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ronsini, C., Solazzo, M.C., Braca, E., Andreoli, G., Vastarella, M.G., Cianci, S., Capozzi, V.A., Torella, M., Cobellis, L., and De Franciscis, P. (2024). Locally Advanced Cervical Cancer: Neoadjuvant Treatment versus Standard Radio-Chemotherapy\u2014An Updated Meta-Analysis. Cancers, 16.","DOI":"10.3390\/cancers16142542"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ygyno.2023.01.023","article-title":"The prognostic value of the presence of pelvic and\/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC)","volume":"171","author":"Ebisch","year":"2023","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Nowakowski, A., Cybulski, M., Buda, I., Janosz, I., Olszak-W\u0105sik, K., Bodzek, P., \u015aliwczy\u0144ski, A., Teter, Z., Olejek, A., and Baranowski, W. (2016). Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155849"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Greenley, R., Bell, S., Rigby, S., Legood, R., Kirkby, V., McKee, M., and the CBIG-SCREEN Consortium (2023). Factors influencing the participation of groups identified as underserved in cervical cancer screening in Europe: A scoping review of the literature. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1144674"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Ussai, S., Seyidov, T., Catalina, N.B., and Khomasuridze, T. (2025). Cervical Screening Systems in Eastern Europe and Central Asia: A Comparative Policy Evaluation. Healthcare, 13.","DOI":"10.3390\/healthcare13222889"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100436","DOI":"10.1016\/j.jcpo.2023.100436","article-title":"Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey","volume":"38","author":"Znaor","year":"2023","journal-title":"J. Cancer Policy"},{"key":"ref_17","unstructured":"Ministry of Health of the Republic of Serbia (2026, February 02). National Cervical Cancer Screening Program, Available online: https:\/\/www.zdravlje.gov.rs."},{"key":"ref_18","unstructured":"Institute of Public Health of Serbia (2026, August 31). \u201cDr Milan Jovanovi\u0107 Batut\u201d. Organized Cervical Cancer Screening. Available online: https:\/\/www.skriningsrbija.rs\/srl\/skrining-raka-grlica-materice\/aktuelnosti\/."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5937\/serbjph2501048S","article-title":"Importance of promotional media activities in cervical cancer prevention","volume":"99","year":"2025","journal-title":"Glas. Javnog Zdr."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"\u0160trbac, M., Joksimovi\u0107, M., Vukovi\u0107, V., Risti\u0107, M., Lon\u010darevi\u0107, G., Kanazir, M., Nikoli\u0107, N., Pustahija, T., Raj\u010devi\u0107, S., and Ljubi\u010di\u0107, S. (2024). Overview of the Implementation of the First Year of Immunization against Human Papillomavirus across Different Administrative Units in Serbia and Montenegro. Vaccines, 12.","DOI":"10.3390\/vaccines12070803"},{"key":"ref_21","first-page":"27","article-title":"CERVICAL CANCER PREVENTION","volume":"10","year":"2024","journal-title":"Prev. Paediatr."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Djordjevic, S., Boricic, K., Radovanovic, S., Vukomanovic, I.S., Mihaljevic, O., and Jovanovic, V. (2024). Demographic and socioeconomic factors associated with cervical cancer screening among women in Serbia. Front. Public Health, 11.","DOI":"10.3389\/fpubh.2023.1275354"},{"key":"ref_23","unstructured":"Statistical Office of the Republic of Serbia (2026, September 01). Estimated Population, 2022, Available online: https:\/\/publikacije.stat.gov.rs\/G2023\/HtmlE\/G20231179.html."},{"key":"ref_24","first-page":"10536","article-title":"CT, MRI, and PET imaging features in cervical cancer staging and lymph node metastasis","volume":"13","author":"Zhu","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.21873\/anticanres.17885","article-title":"Comparative Analysis of FDG-PET Versus CT\/MRI in Staging and Management of Advanced-stage Cervical Cancer","volume":"45","author":"Nayab","year":"2025","journal-title":"Anticancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000453666","article-title":"Incidence of Histologically Proven Pelvic and Para-Aortic Lymph Node Metastases and Rate of Upstaging in Patients with Locally Advanced Cervical Cancer: Results of a Prospective Randomized Trial","volume":"92","author":"Tsunoda","year":"2017","journal-title":"Oncology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/ijgc-2021-003140","article-title":"Prognostic factors in locally advanced cervical cancer with pelvic lymph node metastasis","volume":"32","author":"Pinto","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e077341","DOI":"10.1136\/bmj-2023-077341","article-title":"Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: Population based observational study","volume":"385","author":"Falcaro","year":"2024","journal-title":"BMJ"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ilic, I., and Ilic, M. (2025). Human Papillomavirus Vaccination Coverage Estimates Among the Primary Target Cohort (9\u201314-Year-Old Girls) in the World (2010\u20132024). Vaccines, 13.","DOI":"10.3390\/vaccines13101010"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"103290","DOI":"10.1016\/j.eclinm.2025.103290","article-title":"Global HPV vaccination programs and coverage rates: A systematic review","volume":"84","author":"Han","year":"2025","journal-title":"eClinicalMedicine"},{"key":"ref_31","unstructured":"Institute for Oncology and Radiology of Serbia (2026, September 03). Oncology Centers. Available online: https:\/\/www.ncrc.ac.rs\/onkoloski-centri\/?lang=srcir."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2891\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T09:39:12Z","timestamp":1788773952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/17\/2891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":31,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cancers18172891"],"URL":"https:\/\/doi.org\/10.3390\/cancers18172891","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]}}}